Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.50 |
| ▸ | CPT2 | P23786 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | HMGCR | P04035 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | BHMT | Q93088 | 3/20 | 0.34 |
| ▸ | RET | P07949 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25310553 | 0.88 | KDM4E (0.41) | KDM4EFFAR1CPT2TDP1HMGCR | |
| SCHEMBL30854909 | 0.84 | KDM4E (0.65) | KDM4EFFAR1CPT2TDP1HMGCR | |
| SCHEMBL48109 | 0.84 | KDM4E (0.65) | KDM4EFFAR1CPT2TDP1HMGCR | |
| SCHEMBL15643034 | 0.83 | KDM4E (0.37) | KDM4EFFAR1CPT2TDP1HMGCR | |
| SCHEMBL162441 | 0.83 | KDM4E (0.48) | KDM4EFFAR1CPT2TDP1HMGCR | |
| SCHEMBL18789275 | 0.82 | FFAR1 (0.40) | KDM4EFFAR1CPT2TDP1HMGCR | |
| Hydrochloric Acid SCHEMBL7900820 | 0.81 | KDM4E (0.52) | KDM4EFFAR1CPT2TDP1HMGCR | |
| SCHEMBL4254119 | 0.81 | TDP1 (0.46) | KDM4EFFAR1CPT2TDP1HMGCR | |
| SCHEMBL5856578 | 0.81 | TDP1 (0.46) | KDM4EFFAR1CPT2TDP1HMGCR | |
| SCHEMBL5956694 | 0.81 | KDM4E (0.46) | KDM4EFFAR1CPT2TDP1HMGCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 987 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4549485-A1 | BIOBASED EPOXY THERMOSET MATERIALS | Centre National de la Recherche Scientifique (FR) | 2025-05-07 | — | — | EP | claimed |
| US-12110390-B2 | Solid dispersion, preparation method therefor, chain-extended polyurethane using same, and epoxy resin composition comprising same | SAMYANG CORPORATION (KR) | 2024-10-08 | — | — | US | claimed |
| CN-118271586-A | Method for synthesizing polyester by ionic liquid catalysis | 福州大学 | 2024-07-02 | — | — | CN | claimed |
| US-11912818-B2 | Method for synthesizing aromatic-aliphatic copolyester without catalyst and product thereof | ZHEJIANG UNIVERSITY (CN) | 2024-02-27 | — | — | US | claimed |
| US-20230391948-A1 | METHOD FOR SYNTHESIZING AROMATIC-ALIPHATIC COPOLYESTER WITHOUT CATALYST AND PRODUCT THEREOF | ZHEJIANG UNIVERSITY (CN) | 2023-12-07 | — | — | US | claimed |
| US-20230357257-A1 | NOVEL PROCESS FOR THE SYNTHESIS OF NOROXYMORPHONE FROM MORPHINE | NAVIN SAXENA RESEARCH & TECHNOLOGY PVT. LTD. (IN) | 2023-11-09 | — | — | US | claimed |
| EP-4267583-A1 | NOVEL PROCESS FOR THE SYNTHESIS OF NOROXYMORPHONE FROM MORPHINE | Navin Saxena Research & Technology Pvt. Ltd. (IN) | 2023-11-01 | — | — | EP | claimed |
| CN-114891194-B | Double-functional polymer catalyst for synthesizing polyester and application thereof | 中国科学院长春应用化学研究所 | 2023-08-29 | — | — | CN | claimed |
| US-20230114308-A1 | Flux-Compatible Epoxy-Anhydride Adhesives Compositions for Low-Gap Underfill Applications | HENKEL AG & CO KGAA (DE) | 2023-04-13 | — | — | US | claimed |
| CN-115521447-A | 50/50 fast curing type polyester resin for low-gloss powder coating and preparation method thereof | 黄山市徽州康佳化工有限责任公司 | 2022-12-27 | — | — | CN | claimed |
| US-6472056-B1 | BOUND TO A POLYOLEFIN-BASED PLASTIC CONTAINER, FLEXIBLE LAMINATE PACKAGING MATERIAL, ADHESIVE; RADIATION-CURABLE CARBOXYLIC ACID FUNCTIONAL MONOMER COMPRISES THE HALF ESTER OF A HYDROXY ACRYLATE COMPOUND AND AN ANHYDRIDE | NORTHWEST COATINGS CORP. | 2002-10-29 | — | — | US | claimed |
| WO-2002053562-A1 | KOJIC ACID DERIVATIVE AND PREPARATION METHOD THEREOF | PACIFIC CORPORATION (KR) | 2002-07-11 | — | — | WO | claimed |
| US-6180739-B1 | CYCLODEXTRINS WITH ACRYLATE AND ANHYDRIDES | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION | 2001-01-30 | — | — | US | claimed |
| WO-2001002507-A1 | RADIATION-CURED, LAMINATE FLEXIBLE PACKAGING MATERIAL AND RADIATION-CURABLE, ADHESIVE COMPOSITION | NORTHWEST COATINGS CORP. (US) | 2001-01-11 | — | — | WO | claimed |
| US-6113678-A | Hot melt inks containing polyanhydrides | XEROX CORPORATION (US) | 2000-09-05 | — | — | US | claimed |
| US-5929131-A | Polymerizable cyclodextrin derivatives | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) | 1999-07-27 | — | — | US | claimed |
| US-5792821-A | Polymerizable cyclodextrin derivatives | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) | 1998-08-11 | — | — | US | claimed |
| US-5073570-A | MONO-IODOPROPARGYL ESTERS OF DICARBOXYLIC ANHYDRIDES AND THEIR USE AS ANTIMICROBIAL AGENTS | LONZA INC. (US) | 1991-12-17 | — | — | US | claimed |
| EP-0050977-B1 | CARBOXAMIDE COMPOUNDS AS SRS-A ANTAGONISTS AND A PROCESS FOR PRODUCING SAME | PFIZER INC. (US) | 1983-09-14 | — | — | EP | claimed |
| EP-0050977-A1 | Carboxamide compounds as SRS-A antagonists and a process for producing same | PFIZER INC. (US) | 1982-05-05 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357257-A1 | NOVEL PROCESS FOR THE SYNTHESIS OF NOROXYMORPHONE FROM MORPHINE | OPRM1, OPRK1, OPRD1 | KDM4E 2602/4885FFAR1 1876/4885CPT2 2613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.